Results 341 to 350 of about 982,599 (398)

Paclitaxel/Luteolin Coloaded Dual‐Functional Liposomes for Esophageal Cancer Therapy

open access: yesAdvanced Science, EarlyView.
The authors develop a pH‐sensitive aptamer‐modified liposome (EA2‐PSL‐PTX/LUT) to illustrate a strategy for the precise delivery of combinational chemotherapeutic drugs for esophageal squamous cell carcinoma (ESCC) targeted therapy. EA2‐PSL‐PTX/LUT provides efficient co‐loading, tumor targeting, and controlled release of luteolin and paclitaxel ...
Congyong Sun   +9 more
wiley   +1 more source

Vascular endothelial growth factors in cardiovascular medicine

Journal of Cardiovascular Medicine, 2008
The discovery of vascular endothelial growth factors (VEGFs) and their receptors has considerably improved the understanding of the development and function of endothelial cells. Each member of the VEGF family appears to have a specific function: VEGF-A induces angiogenesis (i.e.
Ugo Testa   +2 more
openaire   +3 more sources

Regulation of vascular permeability by vascular endothelial growth factors

Vascular Pharmacology, 2002
Increased vascular permeability is one of the first stages in both physiological and pathological angiogenesis-the generation of new blood vessels from preexisting vasculature. Although this has been hypothesised to be true in physiological angiogenesis, it is clearly a mark of blood vessel growth in disease.
Steve J Harper, David O. Bates
openaire   +4 more sources

Vascular Endothelial Growth Factor

Ophthalmology, 2007
Vascular endothelial growth factor (VEGF) signalling is a key stimulant of tumour neovascular growth, survival and capillary permeability, which are critical to solid tumour progression. The intracellular signalling responses that induce an angiogenic phenotype are dependent upon VEGF binding to specific transmembrane receptors on the endothelium and ...
Juliane M. Jürgensmeier   +1 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy